EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Validation of diagnosis codes in healthcare databases in Taiwan, a literature review

Yue-Ton Huang iD, Tiffaney Wei, Ya-Ling Huang iD, Yu-Pu Wu iD, K Arnold Chan iD

Pharmacoepidemiology and Drug Safety · 2023

DOI: 10.1002/pds.5608 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2023. Verfasst von Yue-Ton Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Health Data Research Center, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Electronic Health Records, International Classification of Diseases. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 101 Literaturangaben. Gefördert von: National Taiwan University Health Data Research Center, Pfizer Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To compile validation findings of diagnosis codes and related algorithms for health outcomes of interest from National Health Insurance (NHI) or electronic medical records in Taiwan.

Methods

We carried out a literature review of English articles in PubMed® and Embase from 2000 through July 2022 with appropriate search terms. Potentially relevant articles were identified through review of article titles and abstracts, full text search of methodology terms “validation”, “positive predictive value”, and “algorithm” in Subjects & Methods (or Methods) and Results sections of articles, followed by full text review of potentially eligible articles.

Results

We identified 50 published reports with validation findings of diagnosis codes and related algorithms for a wide range of health outcomes of interest in Taiwan, including cardiovascular diseases, stroke, renal impairment, malignancy, diabetes, mental health diseases, respiratory diseases, viral (B and C) hepatitis, and tuberculosis. Most of the reported PPVs were in the 80% ~ 99% range. Assessment of algorithms based on ICD‐10 systems were reported in 8 articles, all published in 2020 or later.

Conclusions

Investigators have published validation reports that may serve as empirical evidence to evaluate the utility of secondary health data environment in Taiwan for research and regulatory purpose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electronic Health RecordsInternational Classification of DiseasesHumansTaiwanPredictive Value of TestsDatabases, FactualAlgorithms

Stichwörter der Autor:innen

Taiwanascertainment algorithmdiagnosis codeshealth outcomes of interesthealthcare databasevalidation

Autor:innen und Institutionen

  • Health Data Research Center, National Taiwan University, Taipei, Taiwan.
  • Epidemiology and Biostatistics, Master of Public Health (MPH), Boston University School of Public Health, Boston, Massachusetts, USA.
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

ORCID-Profile: Yue-Ton Huang, Ya-Ling Huang, Yu-Pu Wu, K Arnold Chan

Förderung

  • National Taiwan University Health Data Research Center
  • Pfizer Taiwan

Zitieren

APA

Huang, Y. T., Wei, T., Huang, Y. L., Wu, Y. P., & Chan, K. A. (2023). Validation of diagnosis codes in healthcare databases in Taiwan, a literature review. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5608

Vancouver

Huang YT, Wei T, Huang YL, Wu YP, Chan KA. Validation of diagnosis codes in healthcare databases in Taiwan, a literature review. Pharmacoepidemiology and Drug Safety. 2023. doi:10.1002/pds.5608

BibTeX
@article{Huang2023,
  author = {Huang, Yue-Ton and Wei, Tiffaney and Huang, Ya-Ling and Wu, Yu-Pu and Chan, K Arnold},
  title = {Validation of diagnosis codes in healthcare databases in Taiwan, a literature review},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2023},
  doi = {10.1002/pds.5608}
}
Kostenlos starten →